BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25224616)

  • 21. Uptake of a patient-centred dynamic choice model for HIV prevention in rural Kenya and Uganda: SEARCH SAPPHIRE study.
    Kabami J; Kakande E; Chamie G; Balzer LB; Petersen ML; Camlin CS; Nyabuti M; Koss CA; Bukusi EA; Kamya MR; Havlir DV; Ayieko J
    J Int AIDS Soc; 2023 Jul; 26 Suppl 1(Suppl 1):e26121. PubMed ID: 37408473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic choice HIV prevention intervention at outpatient departments in rural Kenya and Uganda.
    Koss CA; Ayieko J; Kabami J; Balzer LB; Kakande E; Sunday H; Nyabuti M; Wafula E; Shade SB; Biira E; Opel F; Atuhaire HN; Okochi H; Ogachi S; Gandhi M; Bacon MC; Bukusi EA; Chamie G; Petersen ML; Kamya MR; Havlir DV;
    AIDS; 2024 Mar; 38(3):339-349. PubMed ID: 37861683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Views among Malawian women about joining HIV prevention clinical trials when pregnant.
    Sullivan K; Mtande T; Jaffe E; Rosenberg N; Zimba C; Hoffman I; Little M; Faden R; Lyerly AD
    AIDS Res Ther; 2020 May; 17(1):27. PubMed ID: 32460804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of HIV prevention products on incentives to supply condomless commercial sex among female sex workers in South Africa.
    Quaife M; Vickerman P; Manian S; Eakle R; Cabrera-Escobar MA; Delany-Moretlwe S; Terris-Prestholt F
    Health Econ; 2018 Oct; 27(10):1550-1566. PubMed ID: 29926508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention.
    van der Straten A; Agot K; Ahmed K; Weinrib R; Browne EN; Manenzhe K; Owino F; Schwartz J; Minnis A;
    J Int AIDS Soc; 2018 Mar; 21(3):e25094. PubMed ID: 29600595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women's sexual scripting in the context of universal access to antiretroviral treatment-findings from the HPTN 071 (PopART) trial in South Africa.
    Viljoen L; Hoddinott G; Malunga S; Vanqa N; Mhlakwaphalwa T; Marthinus A; Mcimeli K; Bond V; Seeley J; Bock P; Hayes R; Reynolds L;
    BMC Womens Health; 2021 Oct; 21(1):370. PubMed ID: 34689783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gendered power dynamics and women's negotiation of family planning in a high HIV prevalence setting: a qualitative study of couples in western Kenya.
    Harrington EK; Dworkin S; Withers M; Onono M; Kwena Z; Newmann SJ
    Cult Health Sex; 2016; 18(4):453-69. PubMed ID: 26503879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The promise and peril of pre-exposure prophylaxis (PrEP): using social science to inform prep interventions among female sex workers.
    Syvertsen JL; Robertson Bazzi AM; Scheibe A; Adebajo S; Strathdee SA; Wechsberg WM
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):74-83. PubMed ID: 26050379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population.
    Smith DJ; Wakasiaka S; Hoang TD; Bwayo JJ; Del Rio C; Priddy FH
    J Womens Health (Larchmt); 2008; 17(6):1025-34. PubMed ID: 18681822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya.
    Kaggiah A; Maina CN; Kinuthia J; Barthold D; Hauber B; Tran J; Simoni JM; Graham SM
    BMC Infect Dis; 2024 Apr; 24(1):415. PubMed ID: 38641565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the Barriers and Facilitators to Using Antiretroviral Therapy among Women Living with HIV in Plateau State, Nigeria.
    Osayi EO; Blake SC; Afolaranmi T; Ajayi O; Onyeji J; Sagay AS; Anderson A; Obindo TJ
    Int J Environ Res Public Health; 2024 Apr; 21(5):. PubMed ID: 38791761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maximising HIV prevention by balancing the opportunities of today with the promises of tomorrow: a modelling study.
    Smith JA; Anderson SJ; Harris KL; McGillen JB; Lee E; Garnett GP; Hallett TB
    Lancet HIV; 2016 Jul; 3(7):e289-96. PubMed ID: 27365203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motivations and barriers to uptake and use of female-initiated, biomedical HIV prevention products in sub-Saharan Africa: an adapted meta-ethnography.
    Eakle R; Bourne A; Jarrett C; Stadler J; Larson H
    BMC Public Health; 2017 Dec; 17(1):968. PubMed ID: 29258455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring Attitudes Toward Pre-Exposure Prophylaxis for HIV Prevention Prior to Implementation Among Female Sex Workers in Malaysia: Results from a Qualitative Study.
    Foley S; Keene DE; Shrestha R; Brown SE; Gautam K; Sutherland RA; Maviglia F; Saifi R; Wickersham JA
    Patient Prefer Adherence; 2024; 18():797-807. PubMed ID: 38595805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How effective is effective enough? Opinions of potential end-users of microbicides from a rural South African community.
    Gafos M; Mzimela MA; Ndlovu HB; McCormack S; McGrath N
    AIDS Care; 2013; 25(5):573-8. PubMed ID: 22971053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A decade of PrEP: the evolution of HIV pre-exposure prophylaxis content and sentiments in South African print news media, 2012-2021.
    Coelho SM; Rosen JG; Schulz G; Meek K; Shipp L; Singh C; Willis K; Best A; Mcingana M; Mcloughlin J; Hausler H; Beyrer C; Baral SD; Schwartz SR
    Cult Health Sex; 2024 Apr; ():1-17. PubMed ID: 38656915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring HIV risks, testing and prevention among sub-Saharan African community members in Australia.
    Mullens AB; Kelly J; Debattista J; Phillips TM; Gu Z; Siggins F
    Int J Equity Health; 2018 May; 17(1):62. PubMed ID: 29784050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health system adaptations and considerations to facilitate optimal oral pre-exposure prophylaxis scale-up in sub-Saharan Africa.
    Were DK; Musau A; Atkins K; Shrestha P; Reed J; Curran K; Mohan D
    Lancet HIV; 2021 Aug; 8(8):e511-e520. PubMed ID: 34265282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Young South African Women on Antiretroviral Therapy Perceptions of a Psychological Counselling Program to Reduce Heavy Drinking and Depression.
    Petersen Williams P; Brooke-Sumner C; Joska J; Kruger J; Vanleeuw L; Dada S; Sorsdahl K; Myers B
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32230712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic cultural adaptation of cognitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in western Kenya.
    Papas RK; Sidle JE; Martino S; Baliddawa JB; Songole R; Omolo OE; Gakinya BN; Mwaniki MM; Adina JO; Nafula T; Owino-Ong'or WD; Bryant KJ; Carroll KM; Goulet JL; Justice AC; Maisto SA
    AIDS Behav; 2010 Jun; 14(3):669-78. PubMed ID: 19967441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.